Medium optimization and immobilization of purified fibrinolytic URAK from Bacillus cereus NK1 on PHB nanoparticles

被引:30
作者
Deepak, Venkataraman [1 ]
Ilangovan, Shailaja [1 ]
Sampathkumar, Madhumitha Vangal [1 ]
Victoria, Maria Jacintha [1 ]
Pasha, Sheik Pran Babu Sardar [1 ]
Pandian, Suresh Babu Ram Kumar [1 ]
Gurunathan, Sangiliyandi [1 ]
机构
[1] Kalasalingam Univ, Dept Biotechnol & Chem Engn, Krishnankoil 626190, Tamil Nadu, India
关键词
Bacillus cereus NK1; URAK; RSM; Batch fermentation; Purification; Immobilization; NATTOKINASE PRODUCTION; PLASMINOGEN-ACTIVATOR; GOLD NANOPARTICLES; GLUCOSE-OXIDASE; PURIFICATION; IMPROVEMENT; HEMORRHAGE; STABILITY; NATTO;
D O I
10.1016/j.enzmictec.2010.07.004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Blood clot degrading enzymes are very much useful in combating cardiovascular diseases. An organism primarily isolated from soil, identified as Bacillus cereus NK1 was found to secrete an extracellular protease and the enzyme was identified to degrade fibrin. Response surface methodology was applied to optimize the URAK production medium by B. cereus NK1. The optimized medium obtained from central composite rotary design (CCRD) composed of glucose: 0.5%; soybean meal: 0.5%: calcium chloride: 0.5% and MgSO4: 0.2%. The production of URAK by the optimized medium was 6326.98 FU/ml. Initial experiments showed that the maximum production of URAK occurred at 12th h at pH 9. The efficacy of the medium was further studied in a fermentor as batch fermentation with the same medium optimized by RSM and the yield was comparable with that of the shake flask culture. The maximum activity obtained from fermentor was 6266.66 FU/ml, at the 12th h. PHB was synthesized by B. cereus DV-4 and used for the synthesis of PHB nanoparticles. URAK was purified by ion exchange chromatography and immobilized on PHB nanoparticles. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:297 / 304
页数:8
相关论文
共 35 条
[1]
The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent [J].
Bajzar, L ;
Nesheim, ME ;
Tracy, PB .
BLOOD, 1996, 88 (06) :2093-2100
[2]
BLANN AD, 2005, BMJ-BRIT MED J, V325, P762
[3]
Medium optimization for the production of recombinant nattokinase by Bacillus subtilis using response surface methodology [J].
Chen, Po Ting ;
Chiang, Chung-Jen ;
Chao, Yun-Peng .
BIOTECHNOLOGY PROGRESS, 2007, 23 (06) :1327-1332
[4]
Medium optimization for the production of cyclic adenosine 3′,5′-monophosphate by Microbacterium sp no. 205 using response surface methodology [J].
Chen, Xiao-Chun ;
Bai, Jian-Xin ;
Cao, Jia-Ming ;
Li, Zhen-Jiang ;
Xiong, Jian ;
Zhang, Lei ;
Hong, Yuan ;
Ying, Han-Jie .
BIORESOURCE TECHNOLOGY, 2009, 100 (02) :919-924
[5]
Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics [J].
Chorny, M ;
Fishbein, I ;
Danenberg, HD ;
Golomb, G .
JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) :389-400
[6]
Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent [J].
Collen, D .
NATURE MEDICINE, 1998, 4 (03) :279-284
[7]
Tissue-type plasminogen activator: a historical perspective and personal account [J].
Collen, D ;
Lijnen, HR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (04) :541-546
[8]
Optimization of media composition for Nattokinase production by Bacillus subtilis using response surface methodology [J].
Deepak, V. ;
Kalishwaralal, K. ;
Ramkumarpandian, S. ;
Babu, S. Venkatesh ;
Senthilkumar, S. R. ;
Sangiliyandi, G. .
BIORESOURCE TECHNOLOGY, 2008, 99 (17) :8170-8174
[9]
Purification, immobilization, and characterization of nattokinase on PHB nanoparticles [J].
Deepak, Venkataraman ;
Pandian, Suresh Babu Ram Kumar ;
Kalishwaralal, Kalimuthu ;
Gurunathan, Sangiliyandi .
BIORESOURCE TECHNOLOGY, 2009, 100 (24) :6644-6646
[10]
CHARACTERIZATION OF NATTOKINASE-DEGRADED PRODUCTS FROM HUMAN FIBRINOGEN OR CROSS-LINKED FIBRIN [J].
FUJITA, M ;
ITO, Y ;
HONG, K ;
NISHIMURO, S .
FIBRINOLYSIS, 1995, 9 (03) :157-164